Temporal order of Alzheimer's disease-related cognitive marker changes in BLSA and WRAP longitudinal studies

Murat Bilgel, Rebecca L. Koscik, Yang An, Jerry Ladd Prince, Susan M. Resnick, Sterling C. Johnson, Bruno M. Jedynak

Research output: Contribution to journalArticle

Abstract

Investigation of the temporal trajectories of currently used neuropsychological tests is critical to identifying earliest changing measures on the path to dementia due to Alzheimer's disease (AD). We used the Progression Score (PS) method to characterize the temporal trajectories of measures of verbal memory, executive function, attention, processing speed, language, and mental status using data spanning normal cognition, mild cognitive impairment, and AD from 1,661 participants with a total of 7,839 visits (age at last visit 77.6 SD 9.2) in the Baltimore Longitudinal Study of Aging (BLSA) and 1510 participants with a total of 3,473 visits (age at last visit 59.5 SD 7.4) in the Wisconsin Registry for Alzheimer's Prevention (WRAP). This method aligns individuals in time based on the similarity of their longitudinal measurements to reveal temporal trajectories. As a validation of our methodology, we explored the associations between the individualized cognitive progression scores (Cog-PS) computed by our method and clinical diagnosis. Digit span tests were the first to show declines in both data sets, and were detected mainly among cognitively normal individuals. These were followed by tests of verbal memory, which were in turn followed by Trail Making Tests, Boston Naming Test, and Mini-Mental State Examination. Differences in Cog-PS across the clinical diagnosis and APOE ϵ4 groups were statistically significant, highlighting the potential use of Cog-PS as individualized indicators of disease progression. Identifying cognitive measures that are changing in preclinical AD can lead to the development of novel cognitive tests that are finely tuned to detecting earliest changes.

Original languageEnglish (US)
Pages (from-to)1335-1347
Number of pages13
JournalJournal of Alzheimer's Disease
Volume59
Issue number4
DOIs
StatePublished - Jan 1 2017

Fingerprint

Baltimore
Longitudinal Studies
Registries
Alzheimer Disease
Trail Making Test
Intelligence Tests
Neuropsychological Tests
Executive Function
Cognition
Dementia
Disease Progression
Language

Keywords

  • Alzheimer's disease
  • cognition
  • longitudinal studies
  • neuropsychological tests
  • preclinical

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Temporal order of Alzheimer's disease-related cognitive marker changes in BLSA and WRAP longitudinal studies. / Bilgel, Murat; Koscik, Rebecca L.; An, Yang; Prince, Jerry Ladd; Resnick, Susan M.; Johnson, Sterling C.; Jedynak, Bruno M.

In: Journal of Alzheimer's Disease, Vol. 59, No. 4, 01.01.2017, p. 1335-1347.

Research output: Contribution to journalArticle

Bilgel, Murat ; Koscik, Rebecca L. ; An, Yang ; Prince, Jerry Ladd ; Resnick, Susan M. ; Johnson, Sterling C. ; Jedynak, Bruno M. / Temporal order of Alzheimer's disease-related cognitive marker changes in BLSA and WRAP longitudinal studies. In: Journal of Alzheimer's Disease. 2017 ; Vol. 59, No. 4. pp. 1335-1347.
@article{27f8acd5290f4971b8615c0754fa8989,
title = "Temporal order of Alzheimer's disease-related cognitive marker changes in BLSA and WRAP longitudinal studies",
abstract = "Investigation of the temporal trajectories of currently used neuropsychological tests is critical to identifying earliest changing measures on the path to dementia due to Alzheimer's disease (AD). We used the Progression Score (PS) method to characterize the temporal trajectories of measures of verbal memory, executive function, attention, processing speed, language, and mental status using data spanning normal cognition, mild cognitive impairment, and AD from 1,661 participants with a total of 7,839 visits (age at last visit 77.6 SD 9.2) in the Baltimore Longitudinal Study of Aging (BLSA) and 1510 participants with a total of 3,473 visits (age at last visit 59.5 SD 7.4) in the Wisconsin Registry for Alzheimer's Prevention (WRAP). This method aligns individuals in time based on the similarity of their longitudinal measurements to reveal temporal trajectories. As a validation of our methodology, we explored the associations between the individualized cognitive progression scores (Cog-PS) computed by our method and clinical diagnosis. Digit span tests were the first to show declines in both data sets, and were detected mainly among cognitively normal individuals. These were followed by tests of verbal memory, which were in turn followed by Trail Making Tests, Boston Naming Test, and Mini-Mental State Examination. Differences in Cog-PS across the clinical diagnosis and APOE ϵ4 groups were statistically significant, highlighting the potential use of Cog-PS as individualized indicators of disease progression. Identifying cognitive measures that are changing in preclinical AD can lead to the development of novel cognitive tests that are finely tuned to detecting earliest changes.",
keywords = "Alzheimer's disease, cognition, longitudinal studies, neuropsychological tests, preclinical",
author = "Murat Bilgel and Koscik, {Rebecca L.} and Yang An and Prince, {Jerry Ladd} and Resnick, {Susan M.} and Johnson, {Sterling C.} and Jedynak, {Bruno M.}",
year = "2017",
month = "1",
day = "1",
doi = "10.3233/JAD-170448",
language = "English (US)",
volume = "59",
pages = "1335--1347",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Temporal order of Alzheimer's disease-related cognitive marker changes in BLSA and WRAP longitudinal studies

AU - Bilgel, Murat

AU - Koscik, Rebecca L.

AU - An, Yang

AU - Prince, Jerry Ladd

AU - Resnick, Susan M.

AU - Johnson, Sterling C.

AU - Jedynak, Bruno M.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Investigation of the temporal trajectories of currently used neuropsychological tests is critical to identifying earliest changing measures on the path to dementia due to Alzheimer's disease (AD). We used the Progression Score (PS) method to characterize the temporal trajectories of measures of verbal memory, executive function, attention, processing speed, language, and mental status using data spanning normal cognition, mild cognitive impairment, and AD from 1,661 participants with a total of 7,839 visits (age at last visit 77.6 SD 9.2) in the Baltimore Longitudinal Study of Aging (BLSA) and 1510 participants with a total of 3,473 visits (age at last visit 59.5 SD 7.4) in the Wisconsin Registry for Alzheimer's Prevention (WRAP). This method aligns individuals in time based on the similarity of their longitudinal measurements to reveal temporal trajectories. As a validation of our methodology, we explored the associations between the individualized cognitive progression scores (Cog-PS) computed by our method and clinical diagnosis. Digit span tests were the first to show declines in both data sets, and were detected mainly among cognitively normal individuals. These were followed by tests of verbal memory, which were in turn followed by Trail Making Tests, Boston Naming Test, and Mini-Mental State Examination. Differences in Cog-PS across the clinical diagnosis and APOE ϵ4 groups were statistically significant, highlighting the potential use of Cog-PS as individualized indicators of disease progression. Identifying cognitive measures that are changing in preclinical AD can lead to the development of novel cognitive tests that are finely tuned to detecting earliest changes.

AB - Investigation of the temporal trajectories of currently used neuropsychological tests is critical to identifying earliest changing measures on the path to dementia due to Alzheimer's disease (AD). We used the Progression Score (PS) method to characterize the temporal trajectories of measures of verbal memory, executive function, attention, processing speed, language, and mental status using data spanning normal cognition, mild cognitive impairment, and AD from 1,661 participants with a total of 7,839 visits (age at last visit 77.6 SD 9.2) in the Baltimore Longitudinal Study of Aging (BLSA) and 1510 participants with a total of 3,473 visits (age at last visit 59.5 SD 7.4) in the Wisconsin Registry for Alzheimer's Prevention (WRAP). This method aligns individuals in time based on the similarity of their longitudinal measurements to reveal temporal trajectories. As a validation of our methodology, we explored the associations between the individualized cognitive progression scores (Cog-PS) computed by our method and clinical diagnosis. Digit span tests were the first to show declines in both data sets, and were detected mainly among cognitively normal individuals. These were followed by tests of verbal memory, which were in turn followed by Trail Making Tests, Boston Naming Test, and Mini-Mental State Examination. Differences in Cog-PS across the clinical diagnosis and APOE ϵ4 groups were statistically significant, highlighting the potential use of Cog-PS as individualized indicators of disease progression. Identifying cognitive measures that are changing in preclinical AD can lead to the development of novel cognitive tests that are finely tuned to detecting earliest changes.

KW - Alzheimer's disease

KW - cognition

KW - longitudinal studies

KW - neuropsychological tests

KW - preclinical

UR - http://www.scopus.com/inward/record.url?scp=85027501110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027501110&partnerID=8YFLogxK

U2 - 10.3233/JAD-170448

DO - 10.3233/JAD-170448

M3 - Article

VL - 59

SP - 1335

EP - 1347

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -